ArticleEuropean journal of public health2026
Measuring patient experience of integrated care in multiple sclerosis: development and validation of the Integrated Care Experience Scale (ICES-MS).
Article in European journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
People with multiple sclerosis (MS) need to receive health and social care services from a diverse range of provider organizations, which carries risks such as disjointed care, discontinuities, and duplication. Many innovation programmes aim to provide better integrated and person-centred care (IPCC) for people with chronic conditions, including MS. Measuring patient experience is essential to evaluate interventions meant to shift the service model towards coordinated and personalized care. These transformations are central to global strategies for addressing the needs of ageing populations. AISM-Italian MS Association adapted an 8-item questionnaire, ICES-MS, from a set of questions originally designed for chronic patients in general. A total of 1602 persons with MS living in Italy completed the ICES-MS as a part of a broader survey that included other validated questionnaires on disability (Self-EDSS) and quality of life (EQ-5D-3L and EQ-VAS). Participants' responses were also linked with data from a previous AISM survey on 169 Italian Clinical Centres. Structural, construct, criterion, and known-groups validity of ICES-MS were evaluated. The ICES-MS scale is a robust unidimensional measure of patient experience of IPCC in MS, with strong internal consistency and appropriate convergent validity with EQ-5D-3L and EQ-VAS. ICES-MS scores varied as expected by participants' age and disability level. ICES-MS is a valid, succinct scale to measure patient experience of IPCC care in MS in Italy, and its original design suggests value in exploring its use in other chronic conditions and different countries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.